| scholarly article | Q13442814 |
| P50 | author | Dinesh Bhugra | Q15967266 |
| P2860 | cites work | Schizophrenia in Afro-Caribbean immigrants. | Q51013794 |
| A systematic review of the prevalence of schizophrenia | Q21144720 | ||
| Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study | Q22251379 | ||
| Migration, distress and cultural identity | Q35822551 | ||
| Cultural identities and cultural congruency: a new model for evaluating mental distress in immigrants | Q36018493 | ||
| Incidence and outcome of schizophrenia in whites, African-Caribbeans and Asians in London. | Q39449891 | ||
| Cross-cultural issues in the course and treatment of schizophrenia | Q40825772 | ||
| Increased incidence of psychotic disorders in migrants from the Caribbean to the United Kingdom. | Q46916401 | ||
| The influence of ethnicity and family structure on relapse in first-episode schizophrenia. A comparison of Asian, Afro-Caribbean, and white patients | Q47278726 | ||
| Prognosis for schizophrenia in the Third World: a reevaluation of cross-cultural research | Q47296883 | ||
| Anthropology and psychiatry. The role of culture in cross-cultural research on illness | Q47392610 | ||
| Mental Illness in Immigrant Minorities in London | Q47735201 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | e151; quiz e175 | |
| P577 | publication date | 2005-05-31 | |
| P1433 | published in | PLOS MEDICINE | Q1686921 |
| P1476 | title | The global prevalence of schizophrenia | |
| P478 | volume | 2 |
| Q41994285 | A fundamental role for hippocampal parvalbumin in the dopamine hyperfunction associated with schizophrenia |
| Q33868538 | A joint time-frequency analysis of resting-state functional connectivity reveals novel patterns of connectivity shared between or unique to schizophrenia patients and healthy controls |
| Q34406087 | Abnormal partitioning of hexokinase 1 suggests disruption of a glutamate transport protein complex in schizophrenia |
| Q38186705 | Activation of M1 and M4 muscarinic receptors as potential treatments for Alzheimer's disease and schizophrenia |
| Q48345395 | Acute serotonin and dopamine depletion improves attentional control: findings from the stroop task |
| Q44722660 | Adherence to Antipsychotic Drug Measured by an Arabic Version of Morisky Scale. |
| Q33932787 | Alterations in dopamine system function across the estrous cycle of the MAM rodent model of schizophrenia |
| Q47723761 | Antipsychotic activity of standardized Bacopa extract against ketamine-induced experimental psychosis in mice: Evidence for the involvement of dopaminergic, serotonergic, and cholinergic systems |
| Q37841575 | Applied strategies towards EEG/MEG biomarker identification in clinical and cognitive research |
| Q35447796 | Association study of monoamine oxidase A/B genes and schizophrenia in Han Chinese |
| Q30383282 | Binding of Sulpiride to Seric Albumins. |
| Q47316985 | Blood assessment of the expression levels of matrix metalloproteinase 9 (MMP9) and its natural inhibitor, TIMP1 genes in Iranian schizophrenic patients. |
| Q30583760 | Brain connectivity networks in schizophrenia underlying resting state functional magnetic resonance imaging |
| Q34381557 | Cariprazine, a new, orally active dopamine D2/3 receptor partial agonist for the treatment of schizophrenia, bipolar mania and depression |
| Q58269163 | Characteristics of culturally and linguistically diverse mental health clients |
| Q57170569 | Classification and Prediction of Brain Disorders Using Functional Connectivity: Promising but Challenging |
| Q42556787 | Classification of schizophrenia patients based on resting-state functional network connectivity |
| Q89865506 | Clinical and laboratory characteristics of clozapine-treated patients with schizophrenia referred to a national immunodeficiency clinic reveals a B-cell signature resembling common variable immunodeficiency (CVID) |
| Q24631151 | Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value? |
| Q92457646 | Cultural differences in positive psychotic experiences assessed with the Community Assessment of Psychic Experiences-42 (CAPE-42): a comparison of student populations in the Netherlands, Nigeria and Norway |
| Q41453152 | Cuprizone-induced demyelination in mice: age-related vulnerability and exploratory behavior deficit |
| Q26745793 | Current understandings about cognition and the neurobiological correlates in schizophrenia |
| Q48383225 | DNA methylation signatures of peripheral leukocytes in schizophrenia. |
| Q48032789 | Disruptions in the left frontoparietal network underlie resting state endophenotypic markers in schizophrenia |
| Q34389131 | Does consanguinity increase the risk of schizophrenia? Study based on primary health care centre visits |
| Q104485905 | Dynamic ElecTronic hEalth reCord deTection (DETECT) of individuals at risk of a first episode of psychosis: a case-control development and validation study |
| Q85016653 | Effect of cytomegalovirus infection on temporal lobe development in utero: Quantitative MRI studies |
| Q84280631 | Effects of antipsychotic treatment on psychopathology and motor symptoms. A placebo-controlled study in healthy volunteers |
| Q55452539 | Endocannabinoids and Schizophrenia. |
| Q38051430 | Epidemiology of schizophrenia--an update with a focus on developing countries |
| Q47099281 | Epidemiology of severe mental illness in Hunan province in central China during 2014-2015: A multistage cross-sectional study |
| Q39673251 | Evaluation of the antipsychotic potential of Panax quinquefolium in ketamine induced experimental psychosis model in mice |
| Q57178492 | Expression Analysis of CYFIP1 and CAMKK2 Genes in the Blood of Epileptic and Schizophrenic Patients |
| Q34371549 | Eye-head coordination abnormalities in schizophrenia. |
| Q34618344 | Frequency dependent alterations in regional homogeneity of baseline brain activity in schizophrenia |
| Q39525646 | Frequency-specific alternations in the amplitude of low-frequency fluctuations in schizophrenia |
| Q36663333 | Genome-wide discovered psychosis-risk gene ZNF804A impacts on white matter microstructure in health, schizophrenia and bipolar disorder |
| Q48911787 | Global functional connectivity deficits in schizophrenia depend on behavioral state. |
| Q94336208 | Haloperidol versus risperidone for schizophrenia |
| Q90260077 | Hierarchical Structured Sparse Learning for Schizophrenia Identification |
| Q90333949 | Individual Copy Number of Ribosomal Genes as a Factor of Mental Retardation and Autism Risk and Severity |
| Q92150957 | Kinase network dysregulation in a human induced pluripotent stem cell model of DISC1 schizophrenia |
| Q38093729 | Management of schizophrenia: clinical experience with asenapine. |
| Q38259759 | Maternal immune activation and abnormal brain development across CNS disorders. |
| Q45833153 | Measuring perceived rehabilitation needs of people with schizophrenia in mainland China. |
| Q47816908 | Mental health nurses' experiences of schizophrenia rehabilitation in China and India: a preliminary study |
| Q39959170 | Model-based approaches to increase efficiency of drug development in schizophrenia: a can't miss opportunity |
| Q98464806 | Multifractal and Entropy-Based Analysis of Delta Band Neural Activity Reveals Altered Functional Connectivity Dynamics in Schizophrenia |
| Q41699636 | Multimodal Discrimination of Schizophrenia Using Hybrid Weighted Feature Concatenation of Brain Functional Connectivity and Anatomical Features with an Extreme Learning Machine |
| Q30473395 | Olfactory discrimination varies in mice with different levels of α7-nicotinic acetylcholine receptor expression |
| Q58757322 | Paliperidone Palmitate-Induced Delirium in an Adolescent with Schizophrenia: Case report |
| Q64054184 | Perception regarding the causes of schizophrenia and associated factors among Feresbet district residents: a community based study |
| Q30422050 | Postmortem brain: an underutilized substrate for studying severe mental illness |
| Q35856205 | Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness: a systematic review and meta-analysis |
| Q92580202 | Prevalence of suicide attempts in individuals with schizophrenia: a meta-analysis of observational studies |
| Q38128722 | Racial and ethnic disparities in the use of antipsychotic medication: a systematic review and meta-analysis. |
| Q24200778 | Relapse prevention for schizophrenia |
| Q90553533 | Relationship of Interferon-γ to Cognitive Function in Midlife Women with Schizophrenia |
| Q59941623 | Restoring wild-type-like CA1 network dynamics and behavior during adulthood in a mouse model of schizophrenia |
| Q90672013 | Retinal correlates of psychiatric disorders |
| Q38254316 | Second generation antipsychotic-induced obsessive-compulsive symptoms in schizophrenia: a review of the experimental literature |
| Q90288396 | Sex differences in DEK expression in the anterior cingulate cortex and its association with dementia severity in schizophrenia |
| Q31063019 | Single subject prediction of brain disorders in neuroimaging: Promises and pitfalls |
| Q30416030 | Smoking in schizophrenic patients: A critique of the self-medication hypothesis |
| Q33920674 | Socio demographic profile and utilization pattern of antipsychotic drugs among schizophrenic inpatients: a cross sectional study from western region of Nepal |
| Q30394091 | The Hyperactivity of Efferent Auditory System in Patients with Schizophrenia: A Transient Evoked Otoacoustic Emissions Study. |
| Q39240096 | The impact of CACNA1C gene, and its epistasis with ZNF804A, on white matter microstructure in health, schizophrenia and bipolar disorder1. |
| Q45962638 | The meaning of community rehabilitation for schizophrenia patients in Israel. |
| Q38196727 | The neurobiology of social environmental risk for schizophrenia: an evolving research field |
| Q58181682 | The science and politics of cannabis, drugs and schizophrenia – Commentary on: Cannabis causes schizophrenia? So does nicotine |
| Q39061379 | Time trends in first admission rates for schizophrenia and other psychotic disorders in Taiwan, 1998-2007: a 10-year population-based cohort study |
| Q94566937 | Towards a brain-based predictome of mental illness |
| Q33865310 | Vagal nerve stimulation reverses aberrant dopamine system function in the methylazoxymethanol acetate rodent model of schizophrenia |
Search more.